HIGHLIGHTS
- who: Cristina Papayannidis et al. from the (UNIVERSITY) have published the paper: Acute Myeloid Leukemia Mutations: Therapeutic Implications, in the Journal: (JOURNAL)
- what: AML is a complex disease with a complex genetic landscape.
- how: Both preclinical and clinical data showed that the compound is highly active on D835-FLT3-mutated patients underlying a potentially relevant role of the drug after other FLT3 inhibitor failures.
- future: In the near future hopefully the application of deep molecular approaches may help physicians in the identification of the personal oncogenic signature of every single patient . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.